CUE - SEC Form 4 insider transactions

Chief Legal Compliance Officer Ray Sumita converted options into 18,196 shares and sold $265,628 worth of shares (8,829 units at $30.09), increasing direct ownership by 9% to 118,545 units (SEC Form 4) to satisfy tax liability

VP, Prin. Accounting Officer Meluzio Michael Vincent converted options into 13,647 shares and sold $169,324 worth of shares (5,628 units at $30.09), increasing direct ownership by 20% to 48,961 units (SEC Form 4) (tax liability)

Chief Executive Officer Lin Shao-Lee converted options into 109,179 shares and sold $1,606,562 worth of shares (58,258 units at $27.58), increasing direct ownership by 8% to 705,995 units (SEC Form 4) to cover withholding tax

Chief Financial Officer Ahlers James M was granted 25,500 shares (SEC Form 4)

Amendment: SEC Form 4 filed by Chief Executive Officer Lin Shao-Lee

Chief Medical Officer Borie Dominique Christian was granted 31,500 shares (SEC Form 4)

Director Garzone Pamela was granted 21,800 shares (SEC Form 4)

Director Camardo Daniel A. was granted 21,800 shares (SEC Form 4)

Director Sarraf Pasha was granted 21,800 shares, increasing direct ownership by 202% to 32,595 units (SEC Form 4)

Director Meehan Viola Mong was granted 21,800 shares (SEC Form 4)

VP, Prin. Accounting Officer Meluzio Michael Vincent was granted 40,942 shares (SEC Form 4)

Chief Legal Compliance Officer Ray Sumita was granted 54,589 shares, increasing direct ownership by 100% to 109,178 units (SEC Form 4)

Chief Executive Officer Lin Shao-Lee was granted 327,537 shares, increasing direct ownership by 100% to 655,074 units (SEC Form 4)

SEC Form 4 filed by Director Camardo Daniel A.

SEC Form 4 filed by Chief Executive Officer Lin Shao-Lee

SEC Form 4 filed by Director Meehan Viola Mong

CHIEF EXECUTIVE OFFICER Lin Shao-Lee was granted 327,537 shares (SEC Form 4)

SEC Form 4 filed by Warren Lucinda

SEC Form 4 filed by Sandercock Colin

SEC Form 4 filed by Baker Daniel G.

SEC Form 4 filed by Director Broadfoot Jill Marie

SEC Form 4 filed by Director Garzone Pamela

SEC Form 4 filed by Director Kiener Peter A

SEC Form 4 filed by Director Sarraf Pasha

SEC Form 4 filed by Director Verheyen Patrick

SEC Form 4 filed by Director Morich Frank

SEC Form 4 filed by SVP, GENERAL COUNSEL Sandercock Colin

SEC Form 4 filed by CHIEF DEVELOPMENT OFFICER Baker Daniel G.

SEC Form 4 filed by CHIEF BUSINESS OFFICER Warren Lucinda

SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Azam Usman

SEC Form 4 filed by Director Broadfoot Jill Marie

SEC Form 4 filed by CHIEF FINANCIAL OFFICER Millar Kerri-Ann

SEC Form 4 filed by CHIEF DEVELOPMENT OFFICER Baker Daniel G.

SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Passeri Daniel R

SEC Form 4 filed by SVP, GENERAL COUNSEL Sandercock Colin

SEC Form 4 filed by CHIEF BUSINESS OFFICER Warren Lucinda

SEC Form 4 filed by Chief Medical Officer Levisetti Matteo

SEC Form 4 filed by Director Sarraf Pasha

SEC Form 4 filed by Director Morich Frank

SEC Form 4 filed by Director Kiener Peter A

SEC Form 4 filed by Director Verheyen Patrick

SEC Form 4 filed by Director Driscoll Frederick W

SEC Form 4 filed by Director Garzone Pamela

SEC Form 4 filed by CHIEF DEVELOPMENT OFFICER Baker Daniel G.

SEC Form 4 filed by CHIEF BUSINESS OFFICER Warren Lucinda

SEC Form 4 filed by Fox Michael J

SEC Form 4 filed by Levisetti Matteo

SEC Form 4 filed by Suri Anish

SEC Form 4 filed by Sandercock Colin

SEC Form 4 filed by Millar Kerri-Ann

SEC Form 4 filed by Millar Kerri-Ann

SEC Form 4 filed by Suri Anish

SEC Form 4 filed by Sandercock Colin

SEC Form 4 filed by Levisetti Matteo

SEC Form 4 filed by Passeri Daniel R

SEC Form 4 filed by Levisetti Matteo

SEC Form 4 filed by Garzone Pamela

SEC Form 4 filed by Kiener Peter A

SEC Form 4 filed by Driscoll Frederick W

SEC Form 4 filed by Verheyen Patrick